Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2026-01-29 Capital/Financing Update
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
주권관련사채권의취득결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing titled '주권 관련 사채권의 취득결정' (Decision to Acquire Equity-Related Bonds), which details the acquisition of convertible bonds in another company (GenoBio). This type of disclosure regarding capital allocation, investment in financial instruments, and corporate financing activities falls under the 'Capital/Financing Update' category. It is not a report publication announcement, nor is it a simple regulatory notice, as it provides specific financial terms, acquisition purposes, and board resolution details.
2026-01-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity acquires a significant stake in a listed company. This document details the shareholding changes, the identity of the major shareholder (KumSungBaekJoe Construction Co., Ltd.), and the specific transaction history (buy/sell dates and volumes). This falls under the 'Major Shareholding Notification' category.
2026-01-28 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Gencurix, detailing quarterly and cumulative financial performance (revenue, operating profit, net income) for the period ending December 31, 2025. It explicitly states these are preliminary figures (잠정치) and not yet audited. This fits the definition of an Earnings Release (ER), which provides initial highlights of financial results before the full annual report is finalized. Q4 2025
2026-01-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of a major shareholder (Cho Sang-rae) in Gencurix. This falls under the 'Major Shareholding Notification' category.
2026-01-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including acquisitions, stock options, and collateral agreements by major shareholders and related parties. This falls under the category of Major Shareholding Notification.
2026-01-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This document details the shareholding changes and ownership status of a specific director (Cho Sang-rae) of the company Gencurix. In the provided classification schema, reports detailing personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2026-01-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.